Retina

Anti-VEGF agents are effective in treating DME – but not always indefinitely. Steroids work – but accelerate cataract development.

Ophthalmologists would change recommendations if treating themselves

Statins may interfere with glucose metabolism, and their use might be damaging the diabetic eye. Or perhaps not...

As Second Sight’s Argus II Retinal Prosthesis System nears its 100 patient milestone, we look at how the device has impacted the lives of those implanted

Many astronauts develop eye problems in space. NASA wants to know why, so they’ve established the Vision Impairment and Intracranial Pressure (VIIP) program.

Are people with certain genotypes actively harmed by AREDS supplementation, accelerating AMD?

Why are certain regions of the choroid more prone to disease than others? To answer that, you need proteomics

Imagine prescribing eye drops to treat wet AMD, or delivering genes to the retina of patients with retinitis pigmentosa. Nanotechnology can do both – and it could potentially transform ophthalmology

Popular culture has always viewed eyes as being things of beauty. But there’s more to the eye than the color of your irides.

Oral replacement therapy of the retinoid intermediate that fails to form in some types of Leber congenital amaurosis shows significant promise in an early-phase clinical trial